SilkMatrix is at the founding stage by design. A regulatory-qualified scientist-founder de-risks the hardest early work; the foundation round funds the team that scales it. Below: who builds it today, the roles we are recruiting next, and the advisory base we are assembling.
Founder & CEO
Proved the silk-cryogel bone-fixation concept · ISO 10993 Expert
Full profile →Materials scientists and biomedical engineers — recruited as the R&D validation phase begins.
BuildingRegulatory affairs and quality-systems expertise — engaged ahead of preclinical and clinical phases.
BuildingA clear, sequenced plan — each hire is tied to a development milestone, so capital adds capability exactly when the program needs it. This is a deliberate build, not a gap.
Reproducible, medical-grade silk formulation and characterisation.
Recruiting nextDesign controls, ISO 10993 and QMS — supported by the founder’s expertise.
Phase-gatedScale-up and reproducible production as the device matures.
Phase-gatedSurgeon and go-to-market guidance to keep the device clinically grounded.
EngagingWe are engaging technical and clinical advisors to strengthen scientific rigor and de-risk the path to the clinic.
Silk fibroin / sericin science & processing.
Clinical guidance on fixation needs & design.
Device pathway & ISO 10993 strategy.
Go-to-market & capital strategy.
If you bring biomaterials, clinical, regulatory, or capital expertise, we would value a conversation.